Garcia-Effron Guillermo, Katiyar Santosh K, Park Steven, Edlind Thomas D, Perlin David S
Public Health Research Institute, UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA.
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.
Candida parapsilosis has emerged as a common cause of invasive fungal infection, especially in Latin America and in the neonatal setting. C. parapsilosis is part of a closely related group of organisms that includes the species Candida orthopsilosis and Candida metapsilosis. All three species show elevated MICs for the new echinocandin class drugs caspofungin, micafungin, and anidulafungin relative to other Candida species. Despite potential impacts on therapy, the mechanism behind this reduced echinocandin susceptibility has not been determined. In this report, we investigated the role of a naturally occurring Pro-to-Ala substitution at amino acid position 660 (P660A), immediately distal to the highly conserved hot spot 1 region of Fks1p, in the reduced-echinocandin-susceptibility phenotype. Kinetic inhibition studies demonstrated that glucan synthase from the C. parapsilosis group was 1 to 2 logs less sensitive to echinocandin drugs than the reference enzyme from C. albicans. Furthermore, clinical isolates of C. albicans and C. glabrata which harbor mutations at this equivalent position also showed comparable 2-log decreases in target enzyme sensitivity, which correlated with increased MICs. These mutations also resulted in 2.4- to 18.8-fold-reduced V(max) values relative to those for the wild-type enzyme, consistent with kinetic parameters obtained for C. parapsilosis group enzymes. Finally, the importance of the P660A substitution for intrinsic resistance was confirmed by engineering an equivalent P647A mutation into Fks1p of Saccharomyces cerevisiae. The mutant glucan synthase displayed characteristic 2-log decreases in sensitivity to the echinocandin drugs. Overall, these data firmly indicate that a naturally occurring P660A substitution in Fks1p from the C. parapsilosis group accounts for the reduced susceptibility phenotype.
近平滑念珠菌已成为侵袭性真菌感染的常见病因,尤其是在拉丁美洲和新生儿群体中。近平滑念珠菌是一组密切相关的生物体的一部分,该组包括正平滑念珠菌和间平滑念珠菌。相对于其他念珠菌属,这三个物种对新型棘白菌素类药物卡泊芬净、米卡芬净和阿尼芬净的最低抑菌浓度(MIC)均升高。尽管这可能会对治疗产生影响,但棘白菌素敏感性降低背后的机制尚未确定。在本报告中,我们研究了在Fks1p高度保守的热点1区域紧邻的第660位氨基酸(P660A)处天然发生的脯氨酸到丙氨酸的取代在棘白菌素敏感性降低表型中的作用。动力学抑制研究表明,近平滑念珠菌组的葡聚糖合酶对棘白菌素药物的敏感性比白色念珠菌的参考酶低1至2个对数。此外,在这个等效位置发生突变的白色念珠菌和光滑念珠菌临床分离株也显示出目标酶敏感性有类似的2个对数下降,这与MIC升高相关。这些突变还导致相对于野生型酶的V(max)值降低了2.4至18.8倍,这与近平滑念珠菌组酶获得的动力学参数一致。最后,通过在酿酒酵母的Fks1p中设计等效的P647A突变,证实了P660A取代对固有抗性的重要性。突变的葡聚糖合酶对棘白菌素药物的敏感性显示出特征性的2个对数下降。总体而言,这些数据有力地表明,近平滑念珠菌组Fks1p中天然存在的P660A取代导致了敏感性降低表型。